Chronic granulomatous disease and HLA recombinant gene in a family

J Greally1,2, T Lenehan1,2, P Deasy1,2

  • 1Department of Immunology, Trinity College, Dublin 2.

Insights

This study documents a rare case of chronic granulomatous disease (CGD) in a child. A unique finding of a recombinant HLA gene in the patient or sibling suggests potential implications for immune system research.

Area of Science:

  • Pediatric Immunology
  • Genetic Disorders
  • Human Leukocyte Antigen (HLA) System

Background:

  • Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder.
  • Genetic mutations impair phagocyte function, leading to recurrent infections.
  • The HLA system plays a critical role in immune response and self/non-self recognition.

Purpose of the Study:

  • To document a unique case of CGD in childhood.
  • To investigate the presence of a recombinant gene for HLA expression in the affected patient and sibling.
  • To discuss the potential significance of this genetic finding.

Main Methods:

  • Case study documentation.
  • Genetic analysis to identify recombinant HLA gene.
  • Clinical evaluation of the patient.

Main Results:

  • A case of childhood chronic granulomatous disease (CGD) was identified.
  • A recombinant gene for HLA expression was detected in either the male patient or his female sibling.
  • This finding represents a novel genetic observation in the context of CGD.

Conclusions:

  • The presence of a recombinant HLA gene in a CGD patient or sibling is a significant genetic finding.
  • This discovery may offer new insights into HLA gene regulation and its role in immune disorders.
  • Further research is warranted to explore the functional implications of this recombinant HLA gene.

Related Concept Videos

Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
4.3K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.5K
Genetic Lingo01:11

Genetic Lingo

Overview
116.8K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73